Role of Omega-3 fatty acids in meibomian gland dysfunction

  • Dr. Charu Jain Associate Professor, Subharti Medical College, Meerut (U.P.) India.
  • Dr. V.K. Malik Professor & HOD, Subharti Medical College, Meerut (U.P.) India.
  • Dr. Rohan Bowry JR-3, Subharti Medical College, Meerut (U.P.) India.
Keywords: Meibum quality score, Meibomian gland dysfunction (MGD), Omega-3 fatty acids, Ocular Surface Disease Index

Abstract

Objective: To evaluate the role of omega-3 fatty acids in meibomian gland dysfunction (MGD).

Design: This was a prospective randomized control study that included patients with MGD attending outpatient Department of Ophthalmology, Subharti Medical College, Meerut.

Subjects: 40 patients of both sex above 40 years of age with MGD were included in the study.

Methods: Age matched randomization of patients was done in two groups of 20 each. Patients in group A were given 2 capsules of 300mg omega-3 fatty acids for 12 weeks while patients in group B were given a placebo oral supplement. Patients were examined at one-month interval for 3 months after the initial visit. At each visit Ocular Surface Disease Index (OSDI), Schirmer test, Tear film break up time (TBUT), Fluroscein staining and meibum quality score was evaluated.

Results: After 3 months we found statistically significant improvement in subjective as well as objective parameters of group A patients (p value < .05) as compared to group B patients.

Conclusion: Thus, dietary supplementation with omega-3 fatty acids is an effective treatment modality in meibomian gland dysfunction (MGD).

Downloads

Download data is not yet available.

References

1. Bron AJ, Tiffany JM. The contribution of meibomian disease to dry eye. Ocul Surf. 2004 Apr;2(2):149-65.[pubmed]

2. Gilbard JP. Dry eye, blepharitis and chronic eye irritation: divide and conquer. J Ophthalmic Nurs Technol. 1999 May-Jun;18(3):109-15.[pubmed]

3. Nichols KK, Foulks GN, Bron AJ, et al. The international workshop on meibomian gland dysfunction: executive summary. Invest Ophthalmol Vis Sci. 2011 Mar 30;52(4):1922-9. doi: 10.1167/iovs.10-6997a.[pubmed]

4. Shimazaki J, Sakata M, Tsubota K. Ocular surface changes and discomfort in patients with meibomian gland dysfunction. Arch Ophthalmol. 1995 Oct;113(10):1266-70.[pubmed]

5. McCulley JP, Shine WE. Meibomian gland function and the tear lipid layer. Ocul Surf. 2003 Jul;1(3):97-106.[pubmed]

6. Shine WE, McCulley JP. Polar lipids in human meibomian gland secretions. Curr Eye Res. 2003 Feb;26(2):89-94.[pubmed]

7. Shine WE, McCulley JP. Role of wax ester fatty alcohols in chronic blepharitis. Invest Ophthalmol Vis Sci. 1993 Dec;34(13):3515-21.[pubmed]

8. Solomon A, Dursun D, Liu Z, et al. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease. Invest Ophthalmol Vis Sci. 2001 Sep;42(10):2283-92.[pubmed]

9. Lam H, Bleiden L, de Paiva CS, et al. Tear cytokine profiles in dysfunctional tear syndrome. Am J Ophthalmol. 2009 Feb;147(2):198-205. e1. doi: 10.1016/j.ajo.2008.08.032. Epub 2008 Nov 7.[pubmed]

10. James MJ, Gibson RA, Cleland LG. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr. 2000 Jan;71(1 Suppl):343S-8S. doi: 10.1093/ajcn/71.1.343s.[pubmed]

11. Pinna A, Piccinini P, Carta F. Effect of oral linoleic and gamma-linolenic acid on meibomian gland dysfunction. Cornea. 2007 Apr;26(3):260-4. DOI:10.1097/ICO.0b013e318033d79b.[pubmed]

12. Schiffman RM, Christianson MD, Jacobsen G, et al. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol. 2000 May;118(5):615-21.[pubmed]

13. Wojtowicz JC, Butovich I, Uchiyama E, et al. Pilot, prospective, randomized, double-masked, placebo-controlled clinical trial of an omega-3supplement for dry eye. Cornea. 2011 Mar;30(3):308-14. doi: 10.1097/ICO.0b013e3181f22e03.[pubmed]

14. Oleñik A, Jiménez-Alfaro I, Alejandre-Alba N, Mahillo-Fernández I. A randomized, double-masked study to evaluate the effect of omega-3 fatty acids supplementation in meibomian gland dysfunction. Clin Interv Aging. 2013;8:1133-8. doi: 10.2147/CIA.S48955. Epub 2013 Aug 30.[pubmed]

15. Macsai MS. The role of omega-3 dietary supplementation in blepharitis and meibomian gland dysfunction (an AOS thesis). Trans Am Ophthalmol Soc. 2008;106:336-56.[pubmed]

16. Epitropoulos AT, Donnenfeld ED, Shah ZA, et al. Effect of Oral Re-esterified Omega-3 Nutritional Supplementation on Dry Eyes. Cornea. 2016 Sep;35(9):1185-91. doi: 10.1097/ICO.0000000000000940.[pubmed]

17. Opitz DL, Harthan JS, Frometein SR, et al. Diagnosis and management of meibomian gland dysfunction: optometrists’ perspective. Clin Optom.2015; 2015:59-69.

18. Summerton S. Omega-3s: what they can do for you, whether you agree or disagree with the claims, make sure you know the science. Rev Optom.2015;7:32-8.

19. Nagpal H, Rani N, Yadav S, et al. To study the effects of Omega-3fatty acids in patients with meibomian gland dysfunction: A randomized, prospective controlled study. Journal of Dental and Medical Sciences(JDMS).2017;16(10):24-9.

20. Saif AT. Oral linolenic acid dietary supplementation in posterior blepharitis and meibomian gland dysfunction. Delta J Ophthamol.2017;18(2):51-6.
Role of Omega-3 fatty acids in meibomian gland dysfunction
Published
2018-12-31
How to Cite
Jain, C., Malik, V., & Bowry, R. (2018). Role of Omega-3 fatty acids in meibomian gland dysfunction. Tropical Journal of Ophthalmology and Otolaryngology, 3(4), 79-84. https://doi.org/10.17511/jooo.2018.i04.04
Section
Original Article